Skip to main content
SpringerLink
Log in

Interferon therapy: Pharmacokinetic and pharmacological aspects

  • Brief Review
  • Published:
Archives of Virology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ahstrom, L., Dohlwitz, A., Strander, H., Carlstrom, G., Cantell, K.: Interferon in acute leukemia in children. Lancet1, 166–167 (1974).

    Google Scholar 

  2. Arvin, A. M., Feldman, S., Merigan, T. C.: Human leukocyte interferon in the treatment of varicella in children with cancer: a preliminary controlled trial. Antimicrob. Agents Chemother.13, 605–607 (1978).

    Google Scholar 

  3. Ashwell, G., Morell, A. G.: The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Advanc. Enzymol.41, 99–128 (1974).

    Google Scholar 

  4. Billiau, A., de Somer, P.: Clinical use of interferons in viral infections. In:Stringfellow, D. A. (ed.), Interferon and Interferon Inducers, Clinical Applications, 113–144. New York-Basel: Marcel Dekker 1980.

    Google Scholar 

  5. Billiau, A., de Somer, P., Edy, V. G., de Clercq, E., Heremans, H.: Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans. Antimicrob. Agents Chemother.16, 53–63 (1979).

    Google Scholar 

  6. Billiau, A., Edy, V. G., de Somer, P.: The clinical use of fibroblast interferon. In:Chandra, P. (ed.), Antiviral Mechanism in the Control of Neoplasia, 675–696. New York-London: Plenum Publishing Corp. 1979.

    Google Scholar 

  7. Billiau, A., Heine, J. W., van Damme, J., Heremans, H., de Somer, P.: Tolerability of pure fibroblast interferon in man. Ann. N. Y. Acad. Sci., in press (1980).

  8. Billiau, A., Heremans, H., Ververken, D., van Damme, J., Carton, H.: Tissue distribution of human interferons after exogenous administration in rabbits, monkeys and mice. In preparation (1980).

  9. Billiau, A., van Damme, J., van Leuven, F., Edy, V. G., de Ley, M., Cassiman, J. J., van den Berghe, H., de Somer, P.: Human fibroblast interferon for clinical trials: production, partial purification, and characterization. Antimicrob. Agents Chemother.16, 49–55 (1979).

    Google Scholar 

  10. Bigazzi, P. C.: Cytokines: lymphokine mediators produced by non-lymphoid cells. In:Cohen, S., Pick, E., Oppenheim, J. J. (eds.), The Biology of Lymphokines, 243–257. New York-San Francisco-London: Academic Press 1979.

    Google Scholar 

  11. Bocci, V., Pacini, A., Pessina, G. P., Barigli, V., Russi, M.: Metabolism of interferon: hepatic clearance of native and desialylated interferon. J. gen. Virol.35, 525–534 (1977).

    Google Scholar 

  12. Bose, S., Hickman, J.: Role of carbohydrate moiety in determining the survival of interferon in the circulation. J. biol. Chem.252, 8336–8337 (1977).

    Google Scholar 

  13. Cantell, K., Pyhälä, L.: Circulating interferon in rabbits after administration of human interferon by different routes. J. gen. Virol.20, 97–104 (1973).

    Google Scholar 

  14. Cantell, K., Pyhälä, L.: Pharmacokinetics of human leukocyte interferon. J. inf. Dis.133, A6-A12 (1976).

    Google Scholar 

  15. Cantell, K., Pyhälä, L., Strander, H.: Circulating human interferon after intramuscular injection into animals and man. J. gen. Virol.22, 453–455 (1974).

    Google Scholar 

  16. Carter, W. A., Dolen, J. G., Leong, S. S., Horoszewicz, J. S., Vladutiu, A. O., Leibowitz, A. I., Nolan, J. P.: Purified human fibroblast interferon in vivo: skin reactions and effect on bone marrow precursor cells. Cancer Letters7, 243–249 (1979).

    Google Scholar 

  17. Cesario, T. C.: The effect of body fluids on polynucleotide-induced fibroblast interferon and virus-induced leukocyte interferon. Proc. Soc. exp. Biol. Med.155, 583–587 (1977).

    Google Scholar 

  18. Cesario, T., Vaziri, N., Slater, L., Tilles, J.: Inactivators of fibroblast interferon found in human serum. Infect. Immun.24, 851–855 (1979).

    Google Scholar 

  19. Cheeseman, S. H., Rubin, R. H., Stewart, J. A., Tolkoff-Rubin, N. E., Cosimi, A. B., Cantell, K., Gilbert, J., Winkle, S., Herrin, J. T., Black, P. H., Russell, P. S., Hirsch, M. S.: Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. New Engl. J. Med.300, 1345–1349 (1979).

    Google Scholar 

  20. Christophersen, I. S., Jordal, R., Osther, K., Lindenberg, J., Pedersen, P. H., Berg, K.: Interferon therapy in neoplastic disease. Acta Med. Scand.204, 471–476 (1978).

    Google Scholar 

  21. Cohen, S., Pick, E., Oppenheim, J. J.: Biology of the Lymphokines. New York - San Francisco-London: Academic Press 1979.

    Google Scholar 

  22. de Clercq, E., Edy, V. G., Devlieger, H., Eeckels, R., Desmyter, J.: Intrathecal administration of interferon in neonatal herpes. J. Pediatr.86, 736–739 (1975).

    Google Scholar 

  23. Desmyter, J., Ray, M. B., de Groote, J., Bradburne, A. F., Desmet, V. J., Edy, V. G., Billiau, A., de Somer, P., Mortelmans, J.: Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet11, 645–647 (1976).

    Google Scholar 

  24. Dolen, J. G., Carter, W. A., Horoszewicz, J. S., Vladutiu, A. O., Leibowitz, A. I., Nolan, J. P.: Fibroblast interferon treatment of a patient with chronic active hepatitis. Amer. J. Med.67, 127–131 (1979).

    Google Scholar 

  25. Dunnick, J., Galasso, G. J.: Clinical trials with exogenous interferon: summary of a meeting. J. inf. Dis.139, 109–123 (1979).

    Google Scholar 

  26. Edy, V. G., Billiau, A., de Somer, P.: Comparison of rate of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits. J. inf. Dis.133, A18-A21 (1976).

    Google Scholar 

  27. Edy, V. G., Billiau, A., de Somer, P.: Non-appearance of injected fibroblast interferon in the circulation. Lancet1, 451–452 (1978).

    Google Scholar 

  28. Emödi, G., Just, M., Hernandez, R., Hirt, H. R.: Circulating interferon in man after administration of exogenous human leukocyte interferon. J. natl. Cancer Inst.54, 1045–1049 (1975).

    Google Scholar 

  29. Emödi, G., O'Reilly, R., Müller, A., Everson, L. K., Binswanger, U., Just, M.: Effect of human exogenous leukocyte interferon in cytomegalovirus infections. J. inf. Dis.133, A199-A204 (1976).

    Google Scholar 

  30. Emödi, G., Rufli, T., Just, M., Hernandez, R.: Human interferon therapy for herpes zoster in adults. Scand. J. inf. Dis.7, 1–5 (1975).

    Google Scholar 

  31. Greenberg, H. B., Pollard, R. B., Lutwick, L. I., Gregory, P. B., Robinson, W. S., Merigan, T. C.: Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. New Engl. J. Med.295, 517–522 (1976).

    Google Scholar 

  32. Greenberg, P. L., Mosny, S. A.: Cytotoxic effects of interferonin vitro on granulocytic progenitor cells. Cancer Res.37, 1794–1799 (1977).

    Google Scholar 

  33. Greenberg, S. B., Harmon, M. W., Couch, R. C.: Exogenous interferon: stability and pharmacokinetics. In:Stringfellow, D. A. (ed.), Interferon and Interferon Inducers, Clinical Applications, 57–87. New York-Basel: Marcel Dekker Inc. 1980.

    Google Scholar 

  34. Gresser, I., Maury, C., Tovey, M., Morel-Maroger, L., Pontillon, F.: Progressive glomerulonephritis in mice treated with interferon preparations at birth. Nature263, 420–422 (1976).

    Google Scholar 

  35. Gresser, I., Tovey, M. G.: Antitumor effects of interferon. Biochim. Biophys. Acta516, 231–247 (1978).

    Google Scholar 

  36. Gresser, I., Tovey, M. G., Maury, C., Chouroulinkow, I.: Lethality of interferon preparation for newborn mice. Nature258, 76–78 (1975).

    Google Scholar 

  37. Gutterman, J. U., Blumenschein, G. R., Alexanian, R., Yap, H.-Y., Buzdar, A. U., Cabanillas, F., Hortobagyi, G. N., Hersh, E. M., Rasmussen, S. L., Harmon, M., Kramer, M., Pestka, S.: Leucocyte interferon induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann. intern. Med., in press (1980).

  38. Habif, D. V., Lipton, R., Cantell, K.: Interferon crosses blood-cerebrospinal fluid barrier in monkeys. Proc. Soc. exp. Biol. Med.149, 287–289 (1975).

    Google Scholar 

  39. Hanley, D. F., Wiranowska-Stewart, M., Stewart, W. E., II.: Pharmacology of interferons. I. Pharmacologic distinctions between human leukocyte and fibroblast interferons. Int. J. Immunopharmacol.1, 219–226 (1979).

    Google Scholar 

  40. Heine, J., Billiau, A., van Damme, J., de Somer, P.: Human fibroblast interferon: molecular subpopulations with different pharmacokinetic behaviour. Nature, submitted (1980).

  41. Heine, J., van Damme, J., de Ley, M., Billiau, A., de Somer, P.: Molecular heterogeneity of human fibroblast interferon as revealed by zinc chelate chromatography. J. gen. Virol., submitted (1980).

  42. Heremans, H., Billiau, A., de Somer, P.: Interferon in experimental viral infections in mice: confrontation between tissue interferon levels resulting from the virus infection and from exogenous interferon therapy. Infect. Immun.30, 513–522 (1980).

    Google Scholar 

  43. Hill, N. O., Khan, A., Loeb, E., Pardue, A., Aleman, C., Dorn, G., Hill, J. M.: Clinical trials of high dose human leukocyte interferon. In:Kham, A., Hill, N. O., Dorn, G. L. (eds.), Interferon: Properties and Clinical Uses, 667–680. Dallas: Leland Fikes Foundation Press 1980.

    Google Scholar 

  44. Horoszewicz, J. S., Leong, S. S., Ito, M., Buffett, R. F., Karakousis, C., Holyoke, E., Job, L., Dölen, J. G., Carter, W. A.: Human fibroblast interferon in human neoplasmia: clinical and laboratory study. Cancer Treat. Rep.62, 1899–1906 (1978).

    Google Scholar 

  45. Idestrom, K., Cantell, K., Killander, D., Nilsson, K., Strander, H., Willems, J.: Interferon therapy in myeloma. Acta Med. Scand.205, 149–154 (1979).

    Google Scholar 

  46. Ito, M., Buffett, R. F.: Exogenous interferon: use in humans for treatment of malignancies. In:Stringfellow, D. A. (ed.), Interferon and Interferon Inducers, Clinical Applications, 89–112. New York-Basel: Marcel Dekker Inc. 1980.

    Google Scholar 

  47. Jordan, G. W., Fried, R. P., Merigan, T. C.: Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating antiviral activity and host responses to interferon. J. inf. Dis.130, 56–62 (1974).

    Google Scholar 

  48. Kingham, J. G. C., Ganguly, N. K., Shaari, Z. D., Mendelson, R., McGuire, M J, Holgate, S. J., Cartwright, T., Scott, G. M., Richards, B. M., Wright, R.: Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon. Gut19, 91–94 (1978).

    Google Scholar 

  49. Lee, S. H., Epstein, L. B.: Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophages. Cell. Immunol.50, 177–190 (1980).

    Google Scholar 

  50. Lindsay, H. L., Trown, P. W., Brandt, J., Forbes, M.: Pyrogenicity of Poly I. Poly C in rabbits. Nature223, 717–718 (1969).

    Google Scholar 

  51. Lucero, M., Magdelenat, H., Billardon, C., Fridman, W. H., Pouillart, P., Cantell, K., Billiau, A., Falcoff, E.: In preparation (1980).

  52. McNeill, T. A., Gresser, I.: Inhibition of haemopoietic colony growth by interferon preparations from different sources. Nature—New Biol.244, 173–174 (1973).

    Google Scholar 

  53. Merigan, T. C., Rand, K. H., Pollard, R. B., Abdallah, P. S., Jordan, G. W., Fried, R. P.: Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. New Engl. J. Med.298, 981–987 (1978).

    Google Scholar 

  54. Mellstedt, H., Björkholm, M., Johansson, B., Ahre, A., Holm, G., Strander, H.: Interferon therapy in myelomatosis. Lancet1, 245–247 (1979).

    Google Scholar 

  55. Nissen, C., Speck, B., Emödi, G., Iscove, N. N.: Toxicity of human interferon preparations for human bone marrow cultures. Lancet11, 203–204 (1977).

    Google Scholar 

  56. O'Reilly, R. J., Everson, L. K., Emödi, G., Hansen, J., Smithwick, E. M., Grimes, E., Pahwa, S., Pahwa, R., Schwartz, S., Armstrong, D., Shegal, F. P., Gupta, S., Dupont, B., Good, R. A.: Effects of exogenous interferon in cytomegalovirus infections complicating bone marrow transplantation. Clin. Immunol. Immunopathol.6, 51–61 (1976).

    Google Scholar 

  57. Paulson, G., Kapp, J. P.: Movement of sodium-22, radioiodinated protein and tritiated water from the cisterna magna into the cerebrovascular circulation. J. Neurosurgery27, 138–141 (1967).

    Google Scholar 

  58. Pazin, G. J., Armstrong, J. A., Lam, M. P., Tarr, G. C., Jannetta, P. J., Ho, M.: Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. New Engl. J. Med.301, 225–230 (1979).

    Google Scholar 

  59. Petralli, J. K., Merigan, T. C., Wilbur, J. R.: Circulating interferon after measles vaccination. New Engl. J. Med.273, 198–201 (1965).

    Google Scholar 

  60. Pollard, R. B., Merigan, T. C.: Experience with clinical applications of interferon and interferon inducers. Pharmacol. Ther.2, 783–811 (1978).

    Google Scholar 

  61. Priestman, T. J.: Initial evaluation of human lymphoblastoid interferon in patient with advanced malignant disease. Lancet11, 113–118 (1980).

    Google Scholar 

  62. Scott, G. M., Butler, J. K., Cartwright, T., Richards, B. M., Kingham, J. G., Wright, R., Tyrrell, D. A. J.: Interferon skin reactivity and pyrexial reactions. Lancet11, 402–403 (1977).

    Google Scholar 

  63. Scott, G. M., Cartwright, T., Ledu, G., Dicker, D.: Effect of human fibroblast interferon on vaccination in volunteers. J. biol. Standard.6, 73–76 (1978).

    Google Scholar 

  64. Scott, G. M., Tyrrell, D. A.: Interferon, therapeutic fact or fiction for the '80s? Brit. med. J.280, 1558–1562 (1980).

    Google Scholar 

  65. Siegert, R., Shu, H. L., Kohlhage, H.: Correlation between fever and interferon titer in rabbits after induction with myxoviruses. Life Sci.6, 615–620 (1967).

    Google Scholar 

  66. Stewart, W. E., II: The Interferon System. Wien-New York: Springer 1979.

    Google Scholar 

  67. Strander, H., Cantell, K., Carlström, G., Jokobsson, P. A.: Clinical and laboratory investigations on man: systemic administration of potent interferon to man. J. natl. Cencer Inst.51, 733–742 (1973).

    Google Scholar 

  68. Treuner, J., Niethammer, D., Dannecker, G., Hagmann, R., Neef, V., Hofschneider, P. H.: Successful treatment of nasopharyngeal carcinoma with interferon. Lancet1, 817–818 (1980).

    Google Scholar 

  69. van't Hulle, E., Schellekens, H., Löwenberg, B., de Vries, M. J.: The influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro. Cancer Res.38, 911–914 (1978).

    Google Scholar 

  70. Ververken, D., Carton, H., Billiau, A.: Intrathecal administration of interferon in MS patients? In: Human Immunity in Neurological Disease. Nato Advanced Study Institutes Series24, 624–627 (1978).

    Google Scholar 

  71. Vilček, J., Sulea, I. T., Zerebeckyj, I. L., Yip, Y. K.: Pharmacokinetic properties of human fibroblast and leukocyte interferons in rabbits. J. clin. Microbiol.11, 102–105 (1980).

    Google Scholar 

  72. Weimar, W., Heijtink, R. A., Schalm, S. W., Schellekens, H.: Differential effects of fibroblast and leucocyte interferon in HBsAg positive chronic active hepatitis. Europ. J. clin. Invest.9, 151–154 (1979).

    Google Scholar 

  73. Weimar, W., Heijtink, R. A., Schalm, S. W., van Blankenstein, M., Schellekens, H., Masurel, N., Edy, V. G., Billiau, A., de Somer, P.: Fibroblast interferon in HBsAg-positive chronic active hepatitis. Lancet11, 182 (1977).

    Google Scholar 

  74. Weimar, W., Heijtink, R. A., ten Kate, F. J. P., Schalm, S. W., Masurel, N., Schellekens, H.: Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis. Lancet1, 336–338 (1980).

    Google Scholar 

  75. Weimar, W., Schellekens, H., Lameijer, L. D. F., Masurel, N., Edy, V. G., Billiau, A., de Somer, P.: Double-blind study of interferon administration in renal transplant recipients. Eur. J. clin. Invest.8, 255–258 (1978).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rega Institute for Medical Research, University of Leuven, Leuven, Belgium

    A. Billiau

Authors
  1. A. Billiau
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Billiau, A. Interferon therapy: Pharmacokinetic and pharmacological aspects. Archives of Virology 67, 121–133 (1981). https://doi.org/10.1007/BF01318595

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01318595

Keywords

Search

Navigation